Science and Technology Commercialization //

Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva

OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a…
News //

3 Startups Awarded $200,000 Each to Build Out Teams, Launch Novel Products

Flow Medical, Lismikro, and OrisDX each have been awarded a $200,000 co-investment from the George Shultz Innovation Fund to further develop their technologies. Managed by the Polsky Center for Entrepreneurship…
News //

OrisDX Wins 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers

UPDATE: The investment totals have been updated to reflect additional investment made in the days following the winner announcement. A startup developing saliva-based diagnostics to screen for oral cancers and…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept